TERT and thyroid cancer: BRAFV600E positivity was found in 50% (20) of thyroid cancers, TERT overexpressions was found in 25% (10) of thyroid cancers and dual positivity for BRAFV600E and TERT was found in 15% (6) of thyroid cancers (Table 2).